Literature DB >> 31036650

Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins.

Hemendra Singh Panwar1, Hina Ojha1, Payel Ghosh2, Sagar H Barage3, Sunil Raut1, Arvind Sahu4.   

Abstract

The complement system is highly efficient in targeting pathogens, but lack of its apposite regulation results in host-cell damage, which is linked to diseases. Thus, complement activation is tightly regulated by a series of proteins, which primarily belong to the regulators of complement activation (RCA) family. Structurally, these proteins are composed of repeating complement control protein (CCP) domains where two to four successive domains contribute to the regulatory functions termed decay-accelerating activity (DAA) and cofactor activity (CFA). However, the precise constitution of the functional units and whether these units can be joined to form a larger composition with dual function have not been demonstrated. Herein, we have parsed the functional units for DAA and CFA by constructing chimeras of the decay-accelerating factor (DAF) that exhibits DAA and membrane cofactor protein (MCP) that exhibits CFA. We show that in a four-CCP framework, a functional unit for each of the regulatory activities is formed by only two successive CCPs wherein each participates in the function, albeit CCP2 has a bipartite function. Additionally, optimal activity requires C-terminal domains that enhance the avidity of the molecule for C3b/C4b. Furthermore, by composing a four-CCP DAF-MCP chimera with robust CFA (for C3b and C4b) and DAA (for classical and alternative pathway C3 convertases), named decay cofactor protein, we show that CCP functional units can be linked to design a dual-activity regulator. These data indicate that the regulatory determinants for these two biological processes are distinct and modular in nature.

Entities:  

Keywords:  RCA proteins; complement; complement regulation; decay-accelerating factor; membrane cofactor protein

Year:  2019        PMID: 31036650      PMCID: PMC6525521          DOI: 10.1073/pnas.1818573116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 2.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.

Authors:  D Hourcade; M K Liszewski; M Krych-Goldberg; J P Atkinson
Journal:  Immunopharmacology       Date:  2000-08

3.  Complement regulation at the molecular level: the structure of decay-accelerating factor.

Authors:  P Lukacik; P Roversi; J White; D Esser; G P Smith; J Billington; P A Williams; P M Rudd; M R Wormald; D J Harvey; M D M Crispin; C M Radcliffe; R A Dwek; D J Evans; B P Morgan; R A G Smith; S M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

4.  Crystal structure of the A domain from complement factor B reveals an integrin-like open conformation.

Authors:  Ananyo A Bhattacharya; Mark L Lupher; Donald E Staunton; Robert C Liddington
Journal:  Structure       Date:  2004-03       Impact factor: 5.006

5.  Solution structure of a functionally active fragment of decay-accelerating factor.

Authors:  Stanislava Uhrinova; Feng Lin; Graeme Ball; Krystyna Bromek; Dusan Uhrin; M Edward Medof; Paul N Barlow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

Review 6.  Structure-function relationships of complement receptor type 1.

Authors:  M Krych-Goldberg; J P Atkinson
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

7.  Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb.

Authors:  Dennis E Hourcade; Lynne Mitchell; Lisa A Kuttner-Kondo; John P Atkinson; M Edward Medof
Journal:  J Biol Chem       Date:  2001-11-02       Impact factor: 5.157

8.  Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).

Authors:  Claire L Harris; Rachel J M Abbott; Richard A Smith; B Paul Morgan; Susan M Lea
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

9.  Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46).

Authors:  M K Liszewski; M Leung; W Cui; V B Subramanian; J Parkinson; P N Barlow; M Manchester; J P Atkinson
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

10.  A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.

Authors:  Lisa A Kuttner-Kondo; Megan P Dybvig; Lynne M Mitchell; Nasima Muqim; John P Atkinson; M Edward Medof; Dennis E Hourcade
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

View more
  4 in total

1.  Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins.

Authors:  Hina Ojha; Payel Ghosh; Hemendra Singh Panwar; Rajashri Shende; Aishwarya Gondane; Shekhar C Mande; Arvind Sahu
Journal:  Commun Biol       Date:  2019-08-05

Review 2.  Virus-Encoded Complement Regulators: Current Status.

Authors:  Anwesha Sinha; Anup Kumar Singh; Trupti Satish Kadni; Jayati Mullick; Arvind Sahu
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

Review 3.  Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease.

Authors:  Esther C W de Boer; Anouk G van Mourik; Ilse Jongerius
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

4.  Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein.

Authors:  Aleksandra Urban; Daria Kowalska; Grzegorz Stasiłojć; Alicja Kuźniewska; Anna Skrobińska; Emilia Arjona; Eugenia Castellote Alonso; María Ángeles Fenollosa Segarra; Ilse Jongerius; Robbert Spaapen; Simon Satchell; Marcel Thiel; Stanisław Ołdziej; Santiago Rodriguez de Córdoba; Marcin Okrój
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.